Description: Advanced therapies cover the gap between biotechnological preparations, such as insulin, and medical devices, such as implants and include gene therapy, cell therapy and tissue engineering products Advanced Therapy Medicinal Products (ATMPs) are based on mainly human cells as essential component or as precursor of the active substance
compliance (2635) medical devices (592) regulatory compliance (258) clinical trial (179) atmps (5) advanced therapy medicinal products (4) biotechnological (4) bio-tissues (4) advanced therapy medicinal product (4) impd-documents clinical trials (4)